When consumed in moderation, caffeine is safe and even has some health benefits. But because caffeine is psychoactive, the brain can develop a tolerance and physiological dependence in some people who consume large amounts. Current medical evidence supports that caffeine withdrawal symptoms can occur when stopping the use of caffeine after heavy and prolonged use.
Cutting back or stopping caffeine after prolonged and heavy intake can result in some unpleasant symptoms of withdrawal. Have you ever experienced a bout of irritability, headaches, or difficulty concentrating and know that a cup of coffee is just what you need to pick you up? This may be a sign that you are experiencing a caffeine withdrawal.
What are the symptoms of caffeine withdrawal?
The onset of caffeine withdrawal usually occurs within 12 to 24 hours of your last consumption of caffeine. Headache is the most common symptom of caffeine withdrawal. Other symptoms may include:
- Marked fatigue or drowsiness, decrease in energy
- Dysphoric or depressed mood
- Difficulty concentrating
- Flu-like symptoms (nausea, vomiting, or muscle pain/stiffness)
The severity of the withdrawal symptoms depends on the amount of caffeine you have been using, as well as the abruptness by which you stop.
If you are looking to cut back, or stop using caffeine, a slow reduction of intake over 1 to 2 weeks may make the process more bearable.
Thinking of cutting back your caffeine intake?
Fifty percent of chronic caffeine users will experience symptoms of caffeine withdrawal if they stop. If you are a heavy coffee drinker, it may be more helpful to reduce your coffee intake gradually over time. Gradual reduction will help ease the symptoms of caffeine withdrawal.
- Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010; 75:R77.
- Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 2017; 359:j5024.
- Wikoff D, Welsh BT, Henderson R, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol 2017; 109:585.
- Liu J, Sui X, Lavie CJ, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc 2013; 88:1066.
- Griffiths RR. Principles of Addiction Medicine, Graham AW (Ed), 2003. p.193.
- Uhde TW. Neurobiology of Panic Disorder, Ballenger JC (Ed), p.219
- Happonen P, Läärä E, Hiltunen L, Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr 2008; 99:1354.
- Paganini-Hill A, Kawas CH, Corrada MM. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med 2007; 44:305.
- Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 1999; 53:481.
- Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 2006; 113:2045.
- Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; 366:1891.
- de Vreede-Swagemakers JJ, Gorgels AP, Weijenberg MP, et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol 1999; 52:601.
- Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (Eleventh edition.)
- Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci 2007; 61:263.
- Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 2004; 176:1.